((自动化翻译由路透提供，请见免责声明 ))
10月16日 - ** 经纪公司伯恩斯坦预计，美国生命科学和工具公司的第三季度财报季 "并不可怕"，这对投资者来说 "将是真正的享受"。
** "随着生命科学工具的复苏时间表继续进一步推迟()，一些投资者觉得他们已经被骗了太多次，"经纪商说。
** 伯恩斯坦称，安捷伦 和沃特斯 是第三季度的医疗仪器重磅公司，中国市场的销售和需求出现复苏迹象。
** 经纪公司预计赛默飞 、Revvity 和Avantor 的第三季度业绩 "好坏参半"。
** 券商预计赛默飞 第三季度业绩将好于预期，但将小幅上调年度预期。
** 今年以来，安捷伦股价上涨 4%，WAT 和 AVTR 股价上涨 9%，TMO 股价上涨 13%，RVTY 股价上涨约 14
** 标准普尔 500 指数生命科学工具和服务子指数 今年以来上涨了 9
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.